Clinical and Neuroendocrinological Effects of Estrogens in Postmenopausal Women with Parkinson’s Disease

  • U. Bonuccelli
  • P. Piccini
  • A. Napolitano
  • A. Cagnacci
  • G. B. Melis
  • G. U. Corsini
  • A. Muratorio
Part of the Advances in Behavioral Biology book series (ABBI, volume 39)


Clinical and experimental evidence indicates a modulatory role of estrogens on the activity of nigrostriatal dopaminergic neurons (Hruska, 1985; Van Hartesveld & Joyce, 1986). However, conflicting data make the precise effects of estrogens on nigrostriatal dopaminergic system unclear, suggesting either a facilitatory (Nausieda et al., 1979; Hruska & Silbergeld., 1980; Chiodo et al., 1981) or an inhibitory (Bedard et al., 1978; Chiodo et al., 1979; Euvrard et al., 1979; Gordon, 1980) role.


Postmenopausal Woman Luteinizing Hormone Luteinizing Hormone Level Luteinizing Hormone Secretion Endogenous Opioid System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agid, Y., Javoy-Agid, F., 1985, Peptides and Parkinson’s disease, TINS, 8: 30–36.Google Scholar
  2. Bedard, P., Langelier, P., Villeneuve, A., 1977, Oestrogens and extrapiramidal system. Lancet, II: 1367–1368.Google Scholar
  3. Bedard, P., Dankova, J., Boucher, R., Langelier, P., 1978, Effect of estrogens on apomorphine-induced circling behaviour in the rat. Can. J. Physiol. Pharmacol., 65: 538–541.CrossRefGoogle Scholar
  4. Bedard, P., Langelier, P., Dankova, J., Villeneuve, A., Di Paolo, T., Barden, N., Labrie, F., Boissier, J.R., Euvrard, C., 1979, Estrogens, progesterone, and the extrapyramidal system, Adv. Neurol., 24: 411–422.Google Scholar
  5. Brown, E., Brown, G.H., Kofman, O., Quarrington, B., 1978, Sexual function and affect in parkinsonian men treated with 1-Dopa. Am. J. Psychiatry, 135: 1552–1555.PubMedGoogle Scholar
  6. Chiodo, L.A., Caggiula, A.R., Salter, C.F., 1979, Estrog3en increases both spiperone-induced catalepsy and brain levels of H spiperone in the rat. Brain Res., 172: 360–366.PubMedCrossRefGoogle Scholar
  7. Chiodo, L.A., Caggiula, A.R., Salter, C.F., 1981, Estrogen potentiates the stereotypy induced by dopamine agonists in the rat, Life Sci, 28: 827–835.PubMedCrossRefGoogle Scholar
  8. Conte-Devolx, B., Giraud, B., Castanas, E., Boudouresque, F., Orlando, M., Gillioz, P., Oliver, C., 1981, Effect of neonatal treatment with monosodium glutamate on the secretion of alpha-MSH, beta-endorphin and ACTH in the rat, Neuroendocrinology, 33: 207–211.PubMedCrossRefGoogle Scholar
  9. Den Hartog, W.A., Bethlem, J., 1960, The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralisis agitans, J. Neurol. Neurosurg. Psychiatry, 23: 283–90.CrossRefGoogle Scholar
  10. Eikenburg, D.C., Ravitz, A.J., Gudelsky, G.A., Moore, K.E., 1977, Effects of estrogen on prolactin and tuberoinfundibular dopaminergic neurons, J. Neural. Transm., 40: 235–244.PubMedCrossRefGoogle Scholar
  11. Euvrard, C., Labrie, F., Boissier, J.R., 1979, Effect of estrogen on changes in the activity of striatal cholinergic neurons induced by DA drugs, Brain Res., 169: 215–220.PubMedCrossRefGoogle Scholar
  12. Fahn, S., Elton, R.L., Agid, Y., Barbeau, A., Calne, D.B., Duvoisin, R.C., Hoehn, M.M., Jankovic, J., Klawans, H.L., Lang, A.E., Lataste, X., Liebermann, A.N., Marsden, C.D., Markham, C.H., Mayeux, R., Rinne, U.K., Stern, G.M., Teychenne, P., Yahr, M.D., 1987, Unified Parkinson’s disease rating scale, in: “Recent development in Parkinson’s disease (Vol. II)”, S. Fahn, C.D. Marsden, D.B. Caine, M. Goldstein, eds., Mcmillan Healthcare information, New York.Google Scholar
  13. Fioretti, P., Cagnacci, A., Paoletti, A.M., Gambacciani, M., Soldani, R., Mauro, G.A., Spinetti, A., Melis, G.B., 1989, Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women, J. Endocrinol. Invest., 12: 295–301.PubMedGoogle Scholar
  14. Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975, Mini Mental State, a practical method for grading the cognitive state of patients for the clinician, J. Psychiatry Res., 12: 189–193.CrossRefGoogle Scholar
  15. Giovannini, P., Martinez-Campos, A., Scigliano, G., Caraceni, T., 1981, Morbo di Parkinson ed estrogeni, in: “Atti della 7” Riunione della Lega Italiana per la Lotta contro it Morbo di Parkinson e le Malattie Extrapiramidali“, A. Agnoli, G. Bertolani, eds., D. Guanella, Roma.Google Scholar
  16. Gordon, J.H., 1980,. Modulation of apomorphine-induced stereotipy by estrogen: time course and dose response, Brain Res. Bull., 5: 679–682.PubMedCrossRefGoogle Scholar
  17. Gross, K.M., Matsumoto, A.M., Bremner, W.J., 1987, Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man, J. Clin. Endocrinol. Metab., 64: 675–680.CrossRefGoogle Scholar
  18. Hall,J.E., Brodie, T.D., Badger, T.M., Rivier, J., Vale, W., Conn, P.M., Shoenfeld, D., Crowley, W.F., 1988, Evidence of differential control of FSH and LH secretion by gonadotropìn-releasing hormone ( GnRH) from the use of a GnRH antagonist, J. Clin. Endocrinol. Metab., 63: 524–531.CrossRefGoogle Scholar
  19. Hamilton, M., 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23: 56–62.PubMedCrossRefGoogle Scholar
  20. Hornykiewicz, 0., Kish, S.J., 1986, Biochemical pathophysiology of Parkinson’s disease, Adv. Neurol., 45: 19–34.Google Scholar
  21. Hruska, R.E., Silbergeld, E.K., 1980, Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model, Science, 208: 1466–1467.PubMedCrossRefGoogle Scholar
  22. Hruska, R.E., 1985, Sex hormone exposure and nonreproductive behaviour, Int. J. Ment. Health., 14: 112–134.Google Scholar
  23. Hyyppa, M.T. Langvik, V.A., Rinne U.K., 1978 Plasma pituitary hormones in patients with Parkinson’s disease treated with bromocriptine, J. Neural. Transm., 42: 151–157.PubMedCrossRefGoogle Scholar
  24. Javoy-Agid, F., Ruberg, M., Pique, L., Bertagna, X., Taquet, H., Studler, J.M., Cesselin, F., Epelbaum, J., Agid, Y., 1984, Biochemistry of hypothalamus in Parkinson’s disease, Neurology, 34: 672–675.PubMedCrossRefGoogle Scholar
  25. Koller, W.C., Barr, A., Biary, N., 1982, Estrogen treatment of dyskinetic disorders, Neurology, 32: 547–549.PubMedCrossRefGoogle Scholar
  26. Langston, J.W., Forno, L.S., 1978, The hypothalamus in Parkinson’s disease, Ann. Neurol., 3: 129–133.Google Scholar
  27. Ling, N., Ying, S.Y., Ueno, N., Shimasaki, S., Esh, F., Hotta M., Guillemin, R., 1986, Pituitary FSH is released by a heterodimer of the 8-subunits from the two forms of inhibin, Nature, 321: 779–782.PubMedCrossRefGoogle Scholar
  28. Melis, G.B., Paoletti, A.M., Gambacciani, M., Mais, V., Fioretti, P., 1984,. Evidence that estrogens inhibit LH secretion trough opioids in postmenopausal women, Neuroendocrinology, 39: 60–63. PubMedCrossRefGoogle Scholar
  29. Melis, G.B., Gargiulo T., Pallotti, A., Gambacciani, M., Cagnacci, A., Paoletti, A.M., Petacchi, F.D., Fioretti, P., 1985, Disappearance of opioid control of LH secretion in short term ovariectomized women, J. Endocrinol. Invest., 8 (suppl. 2), 41–46.PubMedGoogle Scholar
  30. Melis, G.B., Cagnacci, A., Gambacciani, M., Paoletti, A.M., Caffi, T., Fioretti, P., 1988, Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal women, Neuroendocrinology, 47: 159–163.PubMedCrossRefGoogle Scholar
  31. Nappi, G., Petraglia, F., Martignoni, E., Facchinetti, F., Bono, G., Genazzani, A.R., 1985, ß-endorphin cerebrospinal fluid decrease in untreated parkinsonian patients, Neurology, 35: 1371–1374.PubMedCrossRefGoogle Scholar
  32. Nausieda, P.A., Koller, W.C., Weiner, W.J., Klawans, H.L. 1979, Modification of postsynaptic dopaminergic sensitivity by female sex hormones, Life Sci., 25: 521–526.PubMedCrossRefGoogle Scholar
  33. Nutt, J.G., Woodward, W.R., Hammerstad, J.P., Carter, J.H., Anderson, J.L., 1984, The on-off phenomenon in Parkinson’s disease. Relation to levodopa absorption and transport, N. Eng. J. Med., 310: 483–488.CrossRefGoogle Scholar
  34. Quigley, M.E., Yen, S.S.C., 1980, The role of endogenous opiates on LH secretion during the menstrual cycle, J. Clin. Endocrinol, Metab., 51: 179–181.CrossRefGoogle Scholar
  35. Raymond, V., Beaulieu, M., Labrie, F., Boissier, J.R., 1978, Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release, Science, 200: 1173–1175.PubMedCrossRefGoogle Scholar
  36. Rasmussen, D.D., Liu, J.H., Wolf, P.K., Jen, S.S.C., 1986,. Gonadotropin-releasing hormone neurosecretion in the human hypothalamus. In vitro regulation by dopamine, J. Clin. Endocrinol., Metab., 62: 479–483.CrossRefGoogle Scholar
  37. Rasmussen, D.D., Liu, J.H., Wolf, P.L., Yen, S.S.C., 1987, Neurosecretion of human hypothalamic immunoreactive ß-endorphin: in vitro regulation by dopamine, Neuroendocrinology, 45: 197–200.PubMedCrossRefGoogle Scholar
  38. Reid, R.L., Quigley, M.E., Yen, S.S.C., 1983, The disappearance of opioidergic regulation of gonadotropin secretion in postmenomausal women, J. Clin. Endocrinol. Metab., 57: 1107–1110.PubMedCrossRefGoogle Scholar
  39. Rinne, U.K., 1979, Neuroendocrine and extrapyramidal dopamine neurons in Parkinson’s disease, in: “Neuroendocrine Correlates in Neurology and Psychiatry”, E.E. Muller, A. Agnoli, eds., Elsevier, Amsterdam, pp. 119–125.Google Scholar
  40. Rivier, C., Rivier, J., Vale, W., 1986, Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat, Science, 234: 205–208.PubMedCrossRefGoogle Scholar
  41. Sandyk, R., 1989, Estrogens and the pathophysiology of Parkinson’s disease, Intern. J. Neurosci., 45: 119–122.CrossRefGoogle Scholar
  42. Shoupe, D., Montz, F.J., Lobo, R.A., 1985, The effects of estrogens and progestins on endogenous opioid activity in oophorectomized women, J. Clin. Endocrinol. Metab., 60: 178–183.PubMedCrossRefGoogle Scholar
  43. Vale, W., Rivier, J., Vaughan, J., McClintock, R., Corrigan, A., Woo, W., Karr, D., Spiess, J., 1986, Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid, Nature, 321, 776–779.PubMedCrossRefGoogle Scholar
  44. Van Hartesveldt, C., Joyce, J.N., 1986, Effects of estrogen on the basal ganglia, Neurosci. Biobehay. Rev., 10: 1–14.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • U. Bonuccelli
    • 1
  • P. Piccini
    • 1
  • A. Napolitano
    • 1
  • A. Cagnacci
    • 2
  • G. B. Melis
    • 2
  • G. U. Corsini
    • 3
  • A. Muratorio
    • 1
  1. 1.Institute of Clinical NeurologyUniversity of PisaItaly
  2. 2.Institute of Obstetrics and GynecologyUniversity of PisaItaly
  3. 3.Institute of PharmacologyUniversity of PisaItaly

Personalised recommendations